Melioidosis causes an under-recognized disease burden to children in endemic areas. Awareness of this disease, improved surveillance and access to laboratory resources, appropriate antibiotics (especially ceftazidime) and quality clinical care together with further research will increase understanding of this complex infection and decrease the associated morbidity and mortality.
|Number of pages||2|
|Journal||Pediatric Infectious Disease Journal|
|Publication status||Published - Jul 2014|